AP-2 Is the Crucial Clathrin Adaptor Protein for CD4 Downmodulation by HIV-1 Nef in Infected Primary CD4+ T Cells. 2015

Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
Helmholtz Zentrum Munich, Institute of Virology, Neuherberg, Germany Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany Universidade de Brasília, Laboratório de Virologia Molecular Faculdade de Ciências da Saúde, Brasília, Brazil.

HIV-1 Nef-mediated CD4 downmodulation involves various host factors. We investigated the importance of AP-1, AP-2, AP-3, V1H-ATPase, β-COP, and ACOT8 for CD4 downmodulation in HIV-1-infected short hairpin RNA (shRNA)-expressing CD4(+) T cells and characterized direct interaction with Nef by Förster resonance energy transfer (FRET). Binding of lentiviral Nefs to CD4 and AP-2 was conserved, and only AP-2 knockdown impaired Nef-mediated CD4 downmodulation from primary T cells. Altogether, among the factors tested, AP-2 is the most important player for Nef-mediated CD4 downmodulation.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015704 CD4 Antigens 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. They are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. T4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120. Antigens, CD4,CD4 Molecule,CD4 Receptor,CD4 Receptors,Receptors, CD4,T4 Antigens, T-Cell,CD4 Antigen,Receptors, Surface CD4,Surface CD4 Receptor,Antigen, CD4,Antigens, T-Cell T4,CD4 Receptor, Surface,CD4 Receptors, Surface,Receptor, CD4,Surface CD4 Receptors,T-Cell T4 Antigens,T4 Antigens, T Cell
D054311 nef Gene Products, Human Immunodeficiency Virus Proteins encoded by the NEF GENES of the HUMAN IMMUNODEFICIENCY VIRUS. nef Protein, Human Immunodeficiency Virus,HIV-3'-orf Protein,nef Protein, HIV,HIV 3' orf Protein,HIV nef Protein
D055785 Gene Knockdown Techniques The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES. Gene Knock Down Techniques,Gene Knock Down,Gene Knock-Down,Gene Knock-Down Techniques,Gene Knockdown,Gene Knock Downs,Gene Knock-Down Technique,Gene Knock-Downs,Gene Knockdown Technique,Gene Knockdowns,Knock Down, Gene,Knock Downs, Gene,Knock-Down Technique, Gene,Knock-Down Techniques, Gene,Knock-Down, Gene,Knock-Downs, Gene,Knockdown Technique, Gene,Knockdown Techniques, Gene,Knockdown, Gene,Knockdowns, Gene,Technique, Gene Knock-Down,Technique, Gene Knockdown,Techniques, Gene Knock-Down,Techniques, Gene Knockdown
D033962 Adaptor Protein Complex 2 An adaptor protein complex primarily involved in the formation of clathrin-related endocytotic vesicles (ENDOSOMES) at the CELL MEMBRANE. Clathrin Adaptor Protein Complex 2,Clathrin Assembly Protein Complex 2,AP-2 Adaptor (Clathrin-Coated Vesicles),AP-2 Protein Complex,Adaptor-Related Protein Complex 2,HA-2 Adaptors,Hydroxyapatite 2 Adaptors,AP 2 Protein Complex,Adaptor Related Protein Complex 2,HA 2 Adaptors

Related Publications

Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
January 2014, eLife,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
February 2023, mBio,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
September 2017, Virology,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
December 1997, The EMBO journal,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
November 1998, Current biology : CB,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
September 2005, Journal of immunology (Baltimore, Md. : 1950),
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
January 1998, Nature,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
November 2005, Virology,
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
October 2015, Science (New York, N.Y.),
Marcos Vinicius Gondim, and Linda Wiltzer-Bach, and Brigitte Maurer, and Carina Banning, and Enrique Arganaraz, and Michael Schindler
May 1999, The EMBO journal,
Copied contents to your clipboard!